G. COCCONI

Publication List Details

Period

1969 - 2009

Number

23

Co-Authors

Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes (2005)

Cocconi, G., Di Blasio, B., Boni, C., Bisagni, G., Rondini, E., Bella, M. A., ...

Background: The role of anthracyclines has been extensively studied in adjuvant chemotherapy, but much less in the primary chemotherapy of early breast carcinoma. This study, comparing CMF...

Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes (2005)

Cocconi, G., Di Blasio, B., Boni, C., Bisagni, G., Rondini, E., Bella, M. A., ...

Background: The role of anthracyclines has been extensively studied in adjuvant chemotherapy, but much less in the primary chemotherapy of early breast carcinoma. This study, comparing CMF...

Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma (2003)

Cocconi, G., Carlini, P., Gamboni, A., Gasperoni, S., RodinĂ², C., Zironi, S., ...

Background: 5-Fluorouracil (5-FU), doxorubicin and methotrexate (FAMTX) and cisplatin, epirubicin, leucovorin and 5-FU (PELF) have both been reported to be superior to the combination 5-FU,...

Letrozole, a new oral non-steroidal aromastase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot study (1996)

Bisagni, G., Cocconi, G., Scaglione, F., Fraschini, F., Pfister, Ch., Trunet, P. F.

Purpose To evaluate the endocrine effects as well as the pharmacokinetic parameters, efficacy and safety of letrozole, a new fourth-generation non-steroidal aromatase in hibitor. Patients and...

The natural history of operable breast cancer after primary treatment (1995)

Cocconi, G.

This paper aimed at reviewing information on the natural history of operable breast carcinoma after primary treatment. Breast carcinoma does not appear as a single disease entity, but as a wide...

Original article: Double-blind, randomized trial for the control of delayed emesis in patients receiving cisplatin: Comparison of placebo vs. adrenocorticotropic hormone (ACTH) (1992)

Passalacqua, R., Cocconi, G., Bella, M., Monici, L., Michiara, M., Bandini, N., ...

Delayed nausea and vomiting is a significant problem for the majority of patients receiving cisplatin. We designed a double-blind randomized study comparing the effects of ACTH and placebo on...

Short report: Cisplatin and etoposide in advanced colorectal carcinoma (1991)

Passalacqua, R., Bisagni, G., Cocconi, G., Boni, C., Di Blasio, B., Ceci, G.

The cisplatin (P) and etoposide (E) combination has been found to be active in several types of solid tumors. It has never been previously tested in advanced colorectal cancer. Thirty-three patients...

Original article: A comparison of continuation versus late intensification followed by discontinuation of chemotherapy in advanced breast cancer. A prospective randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.) (1990)

Cocconi, G., Bisagni, G., Bacchi, M., Buzzi, F., Canaletti, R., Carpi, A., ...

One hundred ninety-eight postmenopausal women with metastatic breast carcinoma were entered in this study. After six induction cycles with cyclophosphamide, methotrexate and 5-fluorouracil (CMF),...

N-(phosphonacetyl)-L-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative group (1982)

Mouridsen, H T, Palshof, T, Cocconi, G, Rotmensz, N, ...

Twenty-nine evaluable patients with extensively pretreated breast cancer received PALA, a new pyrimidine antimetabolite. The drug was given by intravenous infusion over 60 min, at a daily dose of 2.5...

REMARKS ABOUT PULSARS (1969)

Cocconi, G.

Observed features of the pulsars are used to obtain some information about a) their age, b) the spectral shape of the long period pulsar, c) the frequency of " pulsarquakes ".

Kaposi's sarcoma in Italy before and after the AIDS epidemic.

Geddes, M., Franceschi, S., Barchielli, A., Falcini, F., Carli, S., Cocconi, G., ...

The incidence of Kaposi's sarcoma (KS) in 1976-90 was assessed in Italy, taking advantage of a network of nine population-based cancer registries covering, at its maximum, approximately 5.6 million...

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group.

Bontenbal, M., Andersson, M., Wildiers, J., Cocconi, G., Jassem, J., Paridaens, R., ...

The EORTC Breast Cancer Cooperative Group carried out a randomized trial to compare doxorubicin with epirubicin as second-line chemotherapy in patients with metastatic breast cancer. Two hundred and...